James D. Brooks
Publication Details
-
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.
Int J Radiat Oncol Biol Phys. 2012; (2): 877-82
Hypofractionated radiotherapy has an intrinsically different normal tissue and tumor radiobiology. The results of a prospective trial of stereotactic body radiotherapy (SBRT) for prostate cancer with long-term patient-reported toxicity and tumor control rates are presented.
Help
Trial Administration